At the World Drug Safety Congress Europe, ALWIS Solutions Limited stands out as a Gold Sponsor, showcasing its commitment to advancing pharmacovigilance through innovative technology. With over a decade of experience in life sciences, ALWIS specializes in cloud-based platforms that streamline drug safety processes for pharmaceutical companies, Contract Research Organizations [...]
At the Global Drug Safety & PV Outsourcing Summit 2024 held in Mumbai, ALWIS Group participated as a Silver Sponsor, highlighting its commitment to advancing pharmacovigilance through innovative AI-driven solutions. While specific details of their presentation are not publicly available, ALWIS Group’s showcased products included: [...]
We’re proud to announce that a Fortune 500 pharmaceutical leader has officially gone live with ReTrans, our AI-driven literature surveillance platform. This milestone not only reinforces the growing global trust in ALWIS Group’s technological innovations but also showcases the scalability, compliance, and efficiency of ReTrans in enterprise pharmacovigilance environments. As [...]